Scott B. Brown - Net Worth and Insider Trading
Scott B. Brown Net Worth
The estimated net worth of Scott B. Brown is at least $1,957 dollars as of 2024-04-29. Scott B. Brown is the CFO of TRACON Pharmaceuticals Inc and owns about 1,081 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $1,957. Details can be seen in Scott B. Brown's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott B. Brown has not made any transactions after 2022-12-29 and currently still holds the listed stock(s).
Transaction Summary of Scott B. Brown
Scott B. Brown Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott B. Brown owns 1 companies in total, including TRACON Pharmaceuticals Inc (TCON) .
Click here to see the complete history of Scott B. Brown’s form 4 insider trades.
Insider Ownership Summary of Scott B. Brown
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2022-12-29 | Chief Accounting Officer (PAO) |
Scott B. Brown Latest Holdings Summary
Scott B. Brown currently owns a total of 1 stock. Scott B. Brown owns 1,081 shares of TRACON Pharmaceuticals Inc (TCON) as of December 29, 2022, with a value of $1,957.
Latest Holdings of Scott B. Brown
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2022-12-29 | 1,081 | 1.81 | 1,957 |
Holding Weightings of Scott B. Brown
Scott B. Brown Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott B. Brown has made a total of 5 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the acquisition of 175 shares on December 29, 2022, which cost Scott B. Brown around $5,215.
Insider Trading History of Scott B. Brown
- 1
Scott B. Brown Trading Performance
GuruFocus tracks the stock performance after each of Scott B. Brown's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott B. Brown is -9.93%. GuruFocus also compares Scott B. Brown's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott B. Brown within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott B. Brown's insider trading performs compared to the benchmark.
Performance of Scott B. Brown
Average Return
-63.4%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.37 | -9.93 | -45.96 | -63.4 | -63.06 | -68.63 |
| Relative Return to S&P 500(%) | 0.78 | -9.85 | -46.72 | -68.27 | -65.95 | -78.89 |
Scott B. Brown Ownership Network
Ownership Network List of Scott B. Brown
Ownership Network Relation of Scott B. Brown
Scott B. Brown Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Scott B. Brown is the Chief Accounting Officer (PAO) of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Scott B. Brown made 1 insider transaction in TRACON Pharmaceuticals Inc (TCON) with a net purchase of 3,500. Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net purchase of 114,899 shares made by Charles Theuer , a net sale of 4,423,539 shares made by Opaleye Management Inc. , and a net sale of 120 shares made by William R Larue .
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,283 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 23,020 shares were bought by its insiders, resulting in a net sale of 215,263 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Scott B. Brown Mailing Address
Above is the net worth, insider trading, and ownership report for Scott B. Brown. You might contact Scott B. Brown via mailing address: C/o Tracon Pharmaceuticals, Inc., 4350 La Jolla Village Drive, Suite 800, San Diego Ca 92122.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
